Comparison of Media for Agar Dilution Susceptibility Testing of Bordetella Pertussis and Bordetella Parapertussis

Overview

Journal Eur J Clin Microbiol Infect Dis

Publisher Springer

Specialties Infectious Diseases
Microbiology

Date 1995 Sep 1

PMID 8536725

Citations 7

Authors

J E Hoppe

T Tschirner

Affiliations

Soon will be listed here.

Abstract

Antimicrobial susceptibility testing of the fastidious species Bordetella pertussis and Bordetella parapertussis is not standardized. In an attempt to find the optimal medium for agar dilution testing, the activity of erythromycin against Bordetella pertussis and Bordetella parapertussis (34 isolates each) was assessed using homologous broth/agar combinations of Bordet-Gengou, charcoal, Iso-Sensitest (Oxoid) and Mueller-Hinton media. Each medium was supplemented with 5% and 20% whole defibrinated horse blood. Mueller-Hinton medium supplemented with 5% horse blood performed best overall.

Citing Articles

In Vitro Activity of Solithromycin against Bordetella pertussis, an Emerging Respiratory Pathogen.

Hardy D, Vicino D, Fernandes P Antimicrob Agents Chemother. 2016; 60(12):7043-7045.

PMID: 27620481 PMC: 5118982. DOI: 10.1128/AAC.01271-16.

Comparison of three media for agar dilution susceptibility testing of Bordetella pertussis using six antibiotics.

Hoppe J, Paulus T Eur J Clin Microbiol Infect Dis. 1998; 17(6):391-3.

PMID: 9758277 DOI: 10.1007/BF01691567.

State of art in antibacterial susceptibility of Bordetella pertussis and antibiotic treatment of pertussis.

Hoppe J Infection. 1998; 26(4):242-6.

PMID: 9717684 DOI: 10.1007/BF02962373.

Susceptibility testing of Bordetella pertussis.

Hoppe J J Clin Microbiol. 1998; 36(5):1465.

PMID: 9574735 PMC: 104858. DOI: 10.1128/JCM.36.5.1465-1465.1998.

In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine).

Hoppe J, Bryskier A Antimicrob Agents Chemother. 1998; 42(4):965-6.

PMID: 9559823 PMC: 105582. DOI: 10.1128/AAC.42.4.965.

References

Simon C, Simon M, Plieth C . In vitro activity of flomoxef in comparison to other cephalosporins. Infection. 1988; 16(2):131-4. DOI: 10.1007/BF01644322. View

Zackrisson G, Brorson J, Bjornegard B, Trollfors B . Susceptibility of Bordetella pertussis to doxycycline, cinoxacin, nalidixic acid, norfloxacin, imipenem, mecillinam and rifampicin. J Antimicrob Chemother. 1985; 15(5):629-32. DOI: 10.1093/jac/15.5.629. View

Hoppe J, Haug A . Antimicrobial susceptibility of Bordetella pertussis (Part I). Infection. 1988; 16(2):126-30. DOI: 10.1007/BF01644321. View

Hoppe J, Eichhorn A . Activity of new macrolides against Bordetella pertussis and Bordetella parapertussis. Eur J Clin Microbiol Infect Dis. 1989; 8(7):653-4. DOI: 10.1007/BF01968151. View

Barker J, Farrell I . The effect of charcoal on MICs for Legionella. J Antimicrob Chemother. 1986; 17(1):127. DOI: 10.1093/jac/17.1.127. View

Hoppe J, Simon C . In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to seven fluoroquinolones. Antimicrob Agents Chemother. 1990; 34(11):2287-8. PMC: 172042. DOI: 10.1128/AAC.34.11.2287. View

Hoppe J, Weiss A, Worz S . Failure of charcoal-horse-blood broth with cephalexin to significantly increase rate of Bordetella isolation from clinical specimens. J Clin Microbiol. 1988; 26(6):1248-9. PMC: 266578. DOI: 10.1128/jcm.26.6.1248-1249.1988. View

LORIAN V . In vitro simulation of in vivo conditions: physical state of the culture medium. J Clin Microbiol. 1989; 27(11):2403-6. PMC: 267044. DOI: 10.1128/jcm.27.11.2403-2406.1989. View

Appleman M, Hadfield T, Gaines J, Winn R . Susceptibility of Bordetella pertussis to five quinolone antimicrobic drugs. Diagn Microbiol Infect Dis. 1987; 8(2):131-3. DOI: 10.1016/0732-8893(87)90162-3. View

10.

Bannatyne R, Cheung R . Susceptibility of Bordetella pertussis to cephalosporin derivatives and imipenem. Antimicrob Agents Chemother. 1984; 26(4):604-5. PMC: 179976. DOI: 10.1128/AAC.26.4.604. View

11.

BASS J . Erythromycin for treatment and prevention of pertussis. Pediatr Infect Dis. 1986; 5(1):154-7. DOI: 10.1097/00006454-198601000-00051. View

12.

BASS J, Crast F, Kotheimer J, Mitchell I . Susceptibility of Bordetella pertussis to nine antimicrobial agents. Am J Dis Child. 1969; 117(3):276-80. DOI: 10.1001/archpedi.1969.02100030278004. View

13.

Hoppe J, Schlagenhauf M . Comparison of three kinds of blood and two incubation atmospheres for cultivation of Bordetella pertussis on charcoal agar. J Clin Microbiol. 1989; 27(9):2115-7. PMC: 267752. DOI: 10.1128/jcm.27.9.2115-2117.1989. View

14.

Zackrisson G, Brorson J, Trollfors B . Influence of culture medium and inoculum size on susceptibility of Bordetella pertussis to antibacterial agents in vitro. Eur J Clin Microbiol. 1984; 3(6):566-7. DOI: 10.1007/BF02013625. View

15.

Hardy D, Hensey D, Beyer J, Vojtko C, McDonald E, Fernandes P . Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides. Antimicrob Agents Chemother. 1988; 32(11):1710-9. PMC: 175956. DOI: 10.1128/AAC.32.11.1710. View

16.

Hoppe J, Muller J . In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to six new oral cephalosporins. Antimicrob Agents Chemother. 1990; 34(7):1442-3. PMC: 175997. DOI: 10.1128/AAC.34.7.1442. View

17.

Watanabe M, Nakase Y, Aoyama T, Ozawa H, Murase Y, Iwata T . Serotype and drug susceptibility of Bordetella pertussis isolated in Japan from 1975 to 1984. Microbiol Immunol. 1986; 30(5):491-4. DOI: 10.1111/j.1348-0421.1986.tb02975.x. View

18.

SWANSON R, Hardy D, Chu D, Shipkowitz N, Clement J . Activity of temafloxacin against respiratory pathogens. Antimicrob Agents Chemother. 1991; 35(3):423-9. PMC: 245026. DOI: 10.1128/AAC.35.3.423. View

19.

Kurzynski T, Boehm D, Schell R, Allison P . Antimicrobial susceptibilities of Bordetella species isolated in a Multicenter Pertussis Surveillance Project. Antimicrob Agents Chemother. 1988; 32(1):137-40. PMC: 172115. DOI: 10.1128/AAC.32.1.137. View

20.

Hoppe J, Haug A, Botzenhart K . Susceptibility of Bordetella pertussis and Bordetella parapertussis to 24 antibiotics. Chemotherapy. 1987; 33(4):250-4. DOI: 10.1159/000238503. View